Common nerve pain drug linked to suicidal behavior, overdose [Reuters]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Reuters
Common nerve pain drug linked to suicidal behavior, overdose - Reuters 4 Min Read (Reuters Health) - A class of medications used for nerve and muscle pain, including the popular drug Lyrica, increases users’ risks for suicidal behavior, unintentional overdoses, injuries and car accidents - and the risks are particularly high for teens and young adults, new research shows. Lyrica (pregabalin) and the older drug gabapentin, collectively known as gabapentinoids, are approved for treating several types of pain and for preventing seizures in patients with epilepsy. Prescribing of these medications has increased sharply in recent years, while off-label use, meaning for a condition other than the approved indication, is extremely common, Dr. Seena Fazel of the University of Oxford in the UK and colleagues write in the BMJ. There’s some data linking these drugs to an increased risk of suicidal behavior and death from overdose, the authors note, but the evidence is mixed and comes from small s
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage [Yahoo! Finance]Yahoo! Finance
- Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]Yahoo! Finance
- UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Reuters]Reuters
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website